Medical Devices

SciBase Surpasses 300,000 Patients Tested with Nevisense Skin Cancer Detection System

Milestone highlights growing clinical adoption of AI-powered, non-invasive technology for early melanoma diagnosis. ...

Exactech Launches Advanced Shoulder Planning App for Enhanced Surgical Precision

Next-generation platform integrates 3D visualization and smart surgical tools to improve outcomes in shoulder arthroplasty...

CEFALY Unveils CEFALY@Work: A Workplace Wellness Program for Migraine Relief

Innovative initiative brings on-site neurostimulation therapy and support to help employees manage migraines and stay productive....

Abbott Receives FDA Approval for Tendyne™, First Transcatheter Mitral Valve Replacement

Minimally invasive device offers life-saving alternative to open-heart surgery for high-risk patients....

CorePlus Puerto Rico Publishes Groundbreaking Study on 100% Quality Control in Cervical Cytology

Study demonstrates the effectiveness of Whole Slide Imaging and AI in transforming quality assurance in cervical cancer screening....

Covalon Initiates Clinical Study on VALGuard® to Advance Vascular Access Protection

New research to evaluate the effectiveness of VALGuard® in reducing catheter-related complications and enhancing patient safety...

Delta Development Team Revolutionizes Prehospital Blood Storage Across the U.S.

Cutting-Edge Cold Chain Technology Enhances Emergency and Military Lifesaving Capabilities from Coast to Coast....

Dermalyser Earns CE Mark, Ushering in a New Era of AI-Powered Melanoma Detection

European regulatory approval paves the way for Dermalyser’s clinical rollout, enhancing early skin cancer diagnosis through advanced AI technology....

Implantica Showcases RefluxStop™ Breakthrough at Digestive Disease Week 2025

Groundbreaking non-active implant for acid reflux draws global attention and fuels U.S. clinical engagement at world’s premier GI conference....

Sequana Medical Secures €6.3M Convertible Funding to Advance alfapump® Therapy for Liver Disease

SFPIM and Existing Shareholders Back Strategic Funding to Support Liver Disease Therapy Advancements....